Contineum Therapeutics, Inc. (CTNM)
13.44
-0.01
(-0.07%)
USD |
NASDAQ |
Apr 02, 16:00
13.47
+0.03
(+0.22%)
After-Hours: 20:00
Contineum Therapeutics Shareholders Equity (Quarterly) : 260.99M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Coherus Oncology, Inc. | 61.01M |
| ALX Oncology Holdings, Inc. | 25.98M |
| Century Therapeutics, Inc. | 158.94M |
| Climb Bio, Inc. | 160.48M |
| PepGen Inc. | 147.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 278.38M |
| Total Liabilities (Quarterly) | 17.39M |
| Debt to Equity Ratio | 0.0316 |
| Current Ratio | 27.50 |
| Net Debt Paydown Yield | -0.36% |